Page 86 - Overall Coverage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Overall coverage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Overall Coverage Today - Breaking & Trending Today

Servier announce updated overall survival results of exploratory TASCO1 phase II study of LONSURF + bevacizumab in a first-line setting for patients with unresectable mCRC non-eligible for intensive therapy


(2)
Servier announced today updated results from the exploratory phase II TASCO1 study evaluating LONSURF
(trifluridine/tipiracil) bevacizumab and capecitabine bevacizumab (C-B) in a first-line setting for patients with unresectable metastatic colorectal cancer (mCRC) who are non-eligible for intensive therapy.
1 The data were announced today during an oral presentation at the 2021 ASCO Gastrointestinal Cancers Symposium (ASCO-GI). Patients with mCRC who are not eligible for chemotherapy face a large unmet need, with fewer treatment options available to them and lower survival rates.
Colorectal cancer (CRC) makes up 9.7% of total global cancer cases, with almost 1.4 million new cases of CRC each year.
2 In Europe, CRC is the second most common cause of death due to cancer, and those with a metastatic disease have a 5-year survival rate of just 11%. ....

Region Flamande , United States , City Of , United Kingdom , Kostenloser Wertpapierhandel , Patrick Therasse , Eric Van Cutsem , Sonia Marques , Van Cutsem , European Medicines Agency , American Cancer Society , World Health Organisation , Cancers Symposium , Professor Eric Van Cutsem , Servier Late Stage , Life Cycle Management Oncology , Metastatic Colorectal Cancer , Taiho Pharmaceutical , Social Media , Survival Rates , Colorectal Cancer , Rev Anticancer , ஒன்றுபட்டது மாநிலங்களில் , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , சோனியா மார்க்ஸ் ,